Skip to main content

Advertisement

Table 1 Perioperative characteristics of HCC patients

From: Assessment of preoperative exercise capacity in hepatocellular carcinoma patients with chronic liver injury undergoing hepatectomy

Age (years) 70 ± 9
Gender (male/female) 45/16
HBV/HCV/NBC 12/32/15
Child-Pugh class (A/B) 56/5
Diabetes mellitus (+/−) 8/53
WBC count (/μl) 5,000 ± 1,319
Lymphocyte count (/μl) 1,484 ± 580
ICGR15 (%) 16.1 ± 7.8
Albumin (g/dl) 3.8 ± 0.4
Total bilirubin (mg/dl) 0.81 ± 0.21
Cholinesterase (U/l) 232 ± 64
Triglyceride (mg/dl) 85 ± 43
Prothrombin time (%) 92 ± 12
Platelet count (×104/μl) 15 ± 8
AST (U/l) 43 ± 27
ALT (U/l) 42 ± 28
RBP (mg/dl) 3.3 ±1.4
TTR (mg/dl) 16 ±6
BTR 5.09 ± 1.46
AFP (ng/ml) 994 ± 5,028
PIVKA-II (mAU/ml) 1,283 ± 2,209
Esophageal and/or gastric varices (+/−) 15/46
Surgical procedure (limited/anatomic) 35/26
Operation time (min) 329 ± 130
Operative blood loss (ml) 1,011 ± 1,351
Blood transfusion (+/−) 9/52
Tumor size (cm) 4.42 ± 4.09
Associated liver disease  
(normal/fibrosis or hepatitis/cirrhosis) 9/30/22
Morbidity (+/−) 5/56
  1. Data represent the mean ± standard deviation or the number of patients. HBV hepatitis B virus, HCV hepatitis C virus, NBC non-hepatitis B or C virus, WBC white blood cell, ICGR15 indocyanine green retention rate at 15 min; ALT alanine aminotransferase, RBP retinol binding protein, TTR transthyretin, BTR branched chain amino acid/tyrosine ratio, AFP α-fetoprotein, PIVKA-II protein induced by vitamin K absence/antagonism-II.